Aberrant Expression of Functional BAFF-System Receptors by Malignant B-Cell Precursors Impacts Leukemia Cell Survival

• Sara Maia,

  Affiliations Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America, Institute of Molecular Medicine, Lisbon, Portugal

  ⨯
• Marc Pelletier,

  Affiliation Department of Protein Engineering, Biogen Idec, Cambridge, Massachusetts, United States of America

  ⨯
• Jixin Ding,

  Affiliation Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America

  ⨯
• Yen-Ming Hsu,

  Affiliation Department of Protein Engineering, Biogen Idec, Cambridge, Massachusetts, United States of America

  ⨯
• Stephen E. Sallan,

  Affiliation Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Sambasiva P. Rao,

  Current address: Genzyme Corporation, Molecular Immunology, Department of Applied Genomics, Framingham, Massachusetts, United States of America

  Affiliation Department of Immunobiology/Autoimmunity, Biogen Idec, Cambridge, Massachusetts, United States of America

  ⨯
• Lee M. Nadler,

  Affiliation Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Angelo A. Cardoso

  * E-mail: aacardos@iupui.edu

  Affiliations Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America, Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America, Institute of Molecular Medicine, Lisbon, Portugal

  ⨯